Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors-Reference-Cited by-同舟云学术

Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors

Published:2010-12-17 Issue:1 Volume:29 Page:56-61
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Rizzieri David A.,Crout Christopher,Storms Robert,Golob Jared,Long Gwynn D.,Gasparetto Cristina,Sullivan Keith M.,Horwitz Mitchell,Chute John,Lagoo Anand S.,Morris Ashley,Beaven Anne,Yang Yiping,Peterson Bercedis,Li Zhiguo,Chao Nelson J.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357907.2010.535055

Reference27 articles.

1. Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

2. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]

3. REMISSION OF RELAPSED LEUKÆMIA DURING A GRAFT-VERSUS-HOST REACTION A "GRAFT-VERSUS-LEUKÆMIA REACTION" IN MAN?

4. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation;International Journal of Hematologic Oncology;2013-02

2. Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease;New England Journal of Medicine;2011-12